Please login or register to print this page.

The British Journal
of Cardiology

This website is intended for healthcare professionals only

2011, Volume 18 Issue 02, pages 49-96

NEWS

TRIGGER-PCI stopped early

News from the world of

Read More

NEWS

Blood pressure readings more accurate with new device

Blood pressure readings more accurate with new device

A new wrist-mounted device allows more accurate measurement of blood pressure, according to research published recently in the Journal of the American College of Cardiology.

Read More

CLINICAL ARTICLE
Br J Cardiol 2011;18:94−6

The great imposter, the great imitator

Syphilis is a venereal disease that can also be acquired by exposure to infected blood and body fluids. The organism can cross the placenta and

Read More

CLINICAL ARTICLE
Br J Cardiol 2011;18:88−93

Public perception of atrial fibrillation and treatment-related adverse events in the UK

Public perception of atrial fibrillation and treatment-related adverse events in the UK

This study aimed to describe adverse events associated with atrial fibrillation (AF), and the medications used to treat it, and to estimate the importance of

Read More

CLINICAL ARTICLE
Br J Cardiol 2011;18:84−7

Clopidogrel and proton-pump inhibitor interaction: viewpoint and practical clinical approach

Clopidogrel and proton-pump inhibitor interaction: viewpoint and practical clinical approach

The role of clopidogrel after percutaneous coronary intervention (PCI) or acute coronary syndrome (ACS) is well supported by strong clinical evidence, which has led to

Read More

CLINICAL ARTICLE
Br J Cardiol 2011;18:82–3

Dose capping of enoxaparin results in sub-therapeutic anti-Xa level

Dose capping of enoxaparin results in sub-therapeutic anti-Xa level

Enoxaparin is recommended for treatment of patients with acute coronary syndromes (ACS). While plasma monitoring of enoxaparin is not usually required, it may be assessed

Read More

CLINICAL ARTICLE
Br J Cardiol 2011;18:78−81

Drugs for diabetes: part 4 acarbose

Drugs for diabetes: part 4 acarbose

Acarbose is an alpha-glucosidase inhibitor acting in the gastrointestinal tract producing modest reductions in postprandial hyperglycaemia, with negligible risk of hypoglycaemia and weight gain. In

Read More

CLINICAL ARTICLE
Br J Cardiol 2011;18:73−6

Evolving trends in percutaneous coronary intervention

As the proportion of patients above the age of 80 years in the UK is increasing it is likely that in the future cardiac centres

Read More

OBLIQUE VIEW

There’s nothing like a soak in a long, hot bath

There’s nothing like a soak in a long, hot bath

We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this column,

Read More

MEETING REPORT

Magic pixies and the glorified blood vessel

A report from the 5th Annual Scientific Meeting of the Cardiorenal Forum, held at the Royal College of Physicians, London, October 2010, in association with

Read More

NEWS

British Cardiovascular Society: clinical standards

British Cardiovascular Society: clinical standards

In this fourth article from the British Cardiovascular Society (BCS), Dr Simon Ray, BCS Vice-President for Clinical Standards, summarises the major issues of the moment. The BCS

Read More

Close

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

Find out more about our membership benefits

Close

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.

Find out more about our membership benefits